Table 1.
Patient Demographics (n = 193)
| Characteristic | Value |
|---|---|
| Mean ± S.D. age, yr | 60 (12) |
| Gender, % male (no.) | 47 (91) |
| Race, % Caucasian (no.) | 95 (184) |
| Cancer type, % (no.) | |
| Gastrointestinal | 22 (43) |
| Lung | 22 (42) |
| Hematologic | 21 (41) |
| Gynecologic | 11 (22) |
| Breast | 5 (9) |
| Head and neck | 5 (9) |
| Othera | 14 (27) |
| Number of pharmacogenetically actionable medications, % (no.) | |
| 0 | 35 (67) |
| 1 | 38 (73) |
| 2 | 24 (47) |
| 3 | 3 (6) |
aOther: Adrenal, bladder, bone, brain, Erdheim-Chester, neuroendocrine, prostate, renal, sarcoma, skin, or thyroid.